Ugur Sahin – Chief Executive Officer

E812196

Ugur Sahin is a German immunologist, oncologist, and entrepreneur best known as the co-founder and CEO of BioNTech, where he led development of one of the first mRNA-based COVID-19 vaccines.

All labels observed (1)

Label Occurrences
Ugur Sahin – Chief Executive Officer canonical 1

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf entrepreneur
human
immunologist
academicDegree Doctor of Medicine
awardReceived Axel Springer Award
linked to: Axel Springer Prize

Order of Merit of the Federal Republic of Germany
Paul Ehrlich and Ludwig Darmstaedter Prize
citizenship Germany
Turkey
coFounded BioNTech
collaboratedWith Pfizer
countryOfBirth Turkey
dateOfBirth 1965-09-19
educatedAt University of Cologne
University of Saarland
employer BioNTech
ethnicOrigin Turkish
familyName Sahin
fieldOfWork cancer immunotherapy
immunology
mRNA technology
oncology
gender male
givenName Ugur
linked to: Uğur
knownFor co-founding BioNTech
developing mRNA-based COVID-19 vaccine
research in cancer immunotherapy
memberOf German National Academy of Sciences Leopoldina
name Ugur Sahin
notableAchievement led development of one of the first authorized mRNA COVID-19 vaccines at BioNTech
notableRole Chief Executive Officer of BioNTech
notableWork development of BNT162b2 COVID-19 vaccine
occupation businessperson
chief executive officer
immunologist
oncologist
university teacher
placeOfBirth Iskenderun
positionHeld Chief Executive Officer of BioNTech
co-founder of BioNTech
researchInterest T-cell immunology
personalized cancer vaccines
residence Mainz
spouse Ozlem Tureci
linked to: Özlem Türeci
workLocation Germany
Mainz

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

BioNTech positionHeld Ugur Sahin – Chief Executive Officer